New pill aims to tackle obesity and diabetes by calming inflammation
NCT ID NCT07055516
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study tests an experimental drug called NT-0796 in 176 obese adults, some with type 2 diabetes. Participants take the drug or a placebo alongside a reduced-calorie diet and increased physical activity for 6 months. The goal is to see if the drug helps with weight loss and reduces inflammation, which is linked to diabetes complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NT-0796 (oral capsule)
What this could lead to
If it works, this could point toward a new weight-loss and anti-inflammatory treatment for obesity and type 2 diabetes.
What could go wrong
This is an early Phase 2a trial with only 176 participants, so results may not apply to everyone. The drug is still experimental and may not prove effective or safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site
Hialeah, Florida, 33016, United States
-
Investigative Site
Jacksonville, Florida, 32216, United States
-
Investigative Site
Miami, Florida, 33147, United States
-
Investigative Site
Port Orange, Florida, 32127, United States
-
Investigative Site
Columbus, Ohio, 43213, United States
-
Investigative Site
Dallas, Texas, 75230, United States
-
Investigative Site
Manassas, Virginia, 20110, United States
-
Investigative Sites
Marrero, Louisiana, 70006, United States
-
Investigative site
Mesa, Arizona, 85225, United States
-
Investigative site
Los Angeles, California, 90057, United States
-
Investigative site
Cooper City, Florida, 33024, United States